ArticleBMC cancer2020

A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol.

Nicholas F Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.